JP2750017B2 - Novel enzyme, method for producing the same, and method for producing optically active (R) -2-hydroxy-4-phenylbutyric acid - Google Patents

Novel enzyme, method for producing the same, and method for producing optically active (R) -2-hydroxy-4-phenylbutyric acid

Info

Publication number
JP2750017B2
JP2750017B2 JP3131964A JP13196491A JP2750017B2 JP 2750017 B2 JP2750017 B2 JP 2750017B2 JP 3131964 A JP3131964 A JP 3131964A JP 13196491 A JP13196491 A JP 13196491A JP 2750017 B2 JP2750017 B2 JP 2750017B2
Authority
JP
Japan
Prior art keywords
enzyme
phenylbutyric acid
hydroxy
producing
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP3131964A
Other languages
Japanese (ja)
Other versions
JPH04335886A (en
Inventor
健次 左右田
伸佳 中島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DAISERU KAGAKU KOGYO KK
Original Assignee
DAISERU KAGAKU KOGYO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DAISERU KAGAKU KOGYO KK filed Critical DAISERU KAGAKU KOGYO KK
Priority to JP3131964A priority Critical patent/JP2750017B2/en
Publication of JPH04335886A publication Critical patent/JPH04335886A/en
Application granted granted Critical
Publication of JP2750017B2 publication Critical patent/JP2750017B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、新規な酵素およびその
製造方法、並びに前記酵素を用いる光学活性な(R)−
2−ヒドロキシ−4−フェニル酪酸の製造方法に関す
る。
The present invention relates to a novel enzyme, a method for producing the same, and an optically active (R)-
The present invention relates to a method for producing 2-hydroxy-4-phenylbutyric acid.

【0002】[0002]

【従来の技術および発明が解決しようとする課題】近
年、酵素的不斉還元反応を利用して、光学活性体を得る
方法が検討されている。例えば、特公昭61−1159
1号公報、特公平1−27717号公報、特開昭62−
286号公報および特開昭63−32480号公報に
は、乳酸菌が生産する数種の脱水素酵素が報告されてい
る。これらの脱水素酵素は、還元型ニコチンアミド・ア
デニン・ジヌクレオチド(以下、NADHという)を補
酵素として、各種の2−オキソカルボン酸を不斉的に還
元し、対応する光学活性な2−ヒドロキシカルボン酸を
生成する。
2. Description of the Related Art In recent years, a method for obtaining an optically active substance by utilizing an enzymatic asymmetric reduction reaction has been studied. For example, Japanese Patent Publication No. 61-1159
No. 1, Japanese Patent Publication No. 27717/1995, Japanese Unexamined Patent Publication No.
No. 286 and JP-A-63-32480 report several types of dehydrogenases produced by lactic acid bacteria. These dehydrogenases asymmetrically reduce various 2-oxocarboxylic acids using reduced nicotinamide adenine dinucleotide (hereinafter, referred to as NADH) as a coenzyme, and form a corresponding optically active 2-hydroxycarboxylic acid. Produces carboxylic acids.

【0003】また、特開昭63−304979号公報に
は、還元型ニコチンアミド・アデニン・ジヌクレオチド
・リン酸(以下、NADPHという)を補酵素とし、γ
−置換アセト酢酸エステルから(R)−γ−置換−β−
ヒドロキシ酪酸エステルを生成する酵素として、スポロ
ボロマイセス(Sporobolomyces)属に属する菌株から抽出
した還元酵素が開示されている。
Japanese Patent Application Laid-Open No. Sho 63-304979 discloses that reduced nicotinamide / adenine / dinucleotide / phosphate (hereinafter referred to as NADPH) is used as a coenzyme and γ
-Substituted acetoacetic ester to (R) -γ-substituted-β-
As an enzyme for producing hydroxybutyrate, a reductase extracted from a strain belonging to the genus Sporobolomyces is disclosed.

【0004】一方、光学活性な(R)−2−ヒドロキシ
−4−フェニル酪酸は、医薬品などの合成中間体として
有用な化合物である。しかしながら、前記酵素に関し
て、2−オキソ−4−フェニル酪酸を不斉還元し、
(R)−2−ヒドロキシ−4−フェニル酪酸を生成する
活性は知られていない。
On the other hand, optically active (R) -2-hydroxy-4-phenylbutyric acid is a compound useful as a synthetic intermediate for pharmaceuticals and the like. However, for the enzyme, the asymmetric reduction of 2-oxo-4-phenylbutyric acid
The activity of producing (R) -2-hydroxy-4-phenylbutyric acid is not known.

【0005】従って、本発明の目的は、2−オキソ−4
−フェニル酪酸を選択的に不斉還元し、光学活性な
(R)−2−ヒドロキシ−4−フェニル酪酸を効率よく
生成する新規酵素とその製造方法を提供することにあ
る。
Accordingly, an object of the present invention is to provide 2-oxo-4
Another object of the present invention is to provide a novel enzyme that selectively asymmetrically reduces -phenylbutyric acid to efficiently produce optically active (R) -2-hydroxy-4-phenylbutyric acid, and a method for producing the same.

【0006】本発明の他の目的は、酵素の作用により、
2−オキソ−4−フェニル酪酸から光学活性な(R)−
2−ヒドロキシ−4−フェニル酪酸を効率よく得ること
ができる製造方法を提供することにある。
[0006] Another object of the present invention is to provide an
Optically active (R)-is derived from 2-oxo-4-phenylbutyric acid
An object of the present invention is to provide a production method capable of efficiently obtaining 2-hydroxy-4-phenylbutyric acid.

【0007】[0007]

【発明の構成】本発明者らは、2−オキソ−4−フェニ
ル酪酸を不斉還元し、(R)−2−ヒドロキシ−4−フ
ェニル酪酸を生成しうる酵素を探索した結果、ロイコノ
ストック(Leuconostoc)属に属する微生物が、前記目的
を達成しうる酵素を生産することを見いだすと共に、こ
の酵素の理化学的性質を明らかにすることにより、本発
明を完成した。
The present inventors have searched for an enzyme capable of producing (R) -2-hydroxy-4-phenylbutyric acid by asymmetric reduction of 2-oxo-4-phenylbutyric acid. The present invention has been completed by finding that a microorganism belonging to the genus (Leuconostoc) produces an enzyme capable of achieving the above object, and clarifying the physicochemical properties of the enzyme.

【0008】すなわち、本発明は、下記(1) 〜(8) に示
す理化学的性質を有する新規酵素を提供する。
That is, the present invention provides a novel enzyme having the following physicochemical properties (1) to (8).

【0009】(1) 作用および基質特異性:NADPHの
存在下、2−オキソ−4−フェニル酪酸を不斉還元し、
(R)−2−ヒドロキシ−4−フェニル酪酸を生成する (2) 至適pH:6.0付近(リン酸緩衝液) (3) 安定pH範囲:6〜7(リン酸緩衝液) (4) 至適温度:45℃付近(pH6.0) (5) 熱安定性:40℃以下で安定(pH7.2、処理時
間20分) (6) 2−オキソ−4−フェニル酪酸に対するミハエリス
定数Km値:0.29mM (7) 分子量:46000(ゲル濾過法) (8) 阻害剤:塩化水銀およびパラクロロ水銀安息香酸 また、本発明は、ロイコノストック(Leuconostoc)属に
属する微生物を培養し、該培養物から、前記理化学的性
質を有する酵素を採取する新規酵素の製造方法を提供す
る。
(1) Action and substrate specificity: Asymmetric reduction of 2-oxo-4-phenylbutyric acid in the presence of NADPH,
(R) -2-Hydroxy-4-phenylbutyric acid is produced. (2) Optimum pH: around 6.0 (phosphate buffer) (3) Stable pH range: 6-7 (phosphate buffer) (4) ) Optimum temperature: around 45 ° C (pH 6.0) (5) Thermal stability: stable at 40 ° C or less (pH 7.2, treatment time 20 minutes) (6) Michaelis constant Km for 2-oxo-4-phenylbutyric acid Value: 0.29 mM (7) Molecular weight: 46000 (gel filtration method) (8) Inhibitor: mercury chloride and parachloromercuric benzoic acid The present invention also comprises culturing a microorganism belonging to the genus Leuconostoc, The present invention provides a method for producing a novel enzyme for collecting an enzyme having the above physicochemical properties from a culture.

【0010】さらに、本発明は、NADPHの存在下、
前記酵素を、2−オキソ−4−フェニル酪酸に作用させ
て不斉還元する、光学活性な(R)−2−ヒドロキシ−
4−フェニル酪酸の製造方法をも提供する。
[0010] Further, the present invention relates to a method for preparing NADPH,
Optically active (R) -2-hydroxy-, which is asymmetrically reduced by allowing the enzyme to act on 2-oxo-4-phenylbutyric acid.
A method for producing 4-phenylbutyric acid is also provided.

【0011】本発明の新規酵素の起源は、特に限定され
るものではなく、前記理化学的性質を有する酵素を生産
しうる微生物であればよい。好ましい微生物は、例えば
乳酸菌、特にロイコノストック(Leuconostoc)属に属す
る微生物である。これらの微生物の中で好ましい菌株
は、ロイコノストック・デキストラニカム(Leuconostoc
dextranicum)ATCC27310である。
[0011] The origin of the novel enzyme of the present invention is not particularly limited, and may be any microorganism capable of producing the enzyme having the above-mentioned physicochemical properties. Preferred microorganisms are, for example, lactic acid bacteria, especially microorganisms belonging to the genus Leuconostoc. A preferred strain among these microorganisms is Leuconostoc dextranicum (Leuconostoc).
dextranicum) ATCC 27310.

【0012】前記ATCC番号が付された微生物は、ア
メリカン タイプ カルチャー コレクション(Americ
an Type Culture Collection、ATCC)発行の「Cata
logue of Bacteria Phages rDNA Vectors,第16版(1
985)」に記載されており、該ATCCから入手でき
る。
[0012] The microorganisms with the ATCC number may be an American Type Culture Collection (American Type Culture Collection).
an Type Culture Collection, ATCC)
logue of Bacteria Phages rDNA Vectors, 16th edition (1
985) "and is available from the ATCC.

【0013】さらに、これらの微生物は、前記理化学的
性質を有する酵素を生産する限り、野生株、変異株、又
は細胞融合もしくは遺伝子操作法などの遺伝的手法によ
り誘導される組み換え株などのいずれの菌株でも好適に
用いることができる。
Furthermore, these microorganisms may be any of wild-type, mutant, or recombinant strains induced by genetic techniques such as cell fusion or genetic engineering, as long as they produce enzymes having the above-mentioned physicochemical properties. A strain can also be suitably used.

【0014】なお、酵素の理化学的性質は、測定上不可
避的な誤差を含んでいる。従って、例示すれば、本発明
の酵素には、下記の理化学的性質を有する酵素も含まれ
る。
[0014] The physicochemical properties of the enzyme include unavoidable errors in measurement. Therefore, by way of example, the enzymes of the present invention also include enzymes having the following physicochemical properties.

【0015】(2) 至適pH:5.5〜6.5程度、 (3) 安定なpH範囲:5.5〜7.5程度、 (4) 至適温度:40〜50℃程度、 (6) 2−オキソ−4−フェニル酪酸に対するミハエリス
定数Km値:0.2〜0.5mM程度 (7) 分子量:40000〜50000程度 前記酵素は、前記(1) 〜(8) の理化学的性質に加えて、
(9) NADPHの存在下、アセトアルデヒド、n−ブチ
ルアルデヒドなどのアルデヒド類、2−オキソヘキサン
酸、2−オキソオクタン酸などのケトン類を還元し、こ
れらに対応する等モルのアルコールを生成する作用を有
するのが好ましい。
(2) Optimum pH: about 5.5 to 6.5, (3) Stable pH range: about 5.5 to 7.5, (4) Optimum temperature: about 40 to 50 ° C., ( 6) Michaelis constant Km value for 2-oxo-4-phenylbutyric acid: about 0.2 to 0.5 mM (7) Molecular weight: about 40000 to 50,000 The enzyme has the physicochemical properties described in (1) to (8) above. in addition,
(9) An action of reducing aldehydes such as acetaldehyde and n-butyraldehyde and ketones such as 2-oxohexanoic acid and 2-oxooctanoic acid in the presence of NADPH to produce an equimolar alcohol corresponding thereto. It is preferred to have

【0016】前記酵素は、NADHではなく、補酵素と
してのNADPHの存在下、2−オキソ−4−フェニル
酪酸を選択的に不斉還元する。
The enzyme selectively asymmetrically reduces 2-oxo-4-phenylbutyric acid in the presence of NADPH as a coenzyme instead of NADH.

【0017】本発明の酵素は、前記微生物を培地で培養
し、培養菌体から抽出精製することにより得ることがで
きる。
The enzyme of the present invention can be obtained by culturing the microorganism in a medium and extracting and purifying the microorganism from the cultured cells.

【0018】培地は、微生物が増殖し得るものであれば
特に制限されない。培地の炭素源としては、上記微生物
が利用可能であればいずれも使用でき、例えば、グルコ
ース、フルクトース、シュクロース、デキストリン、デ
ンプンなどの糖類;ソルビトール、エタノール、グリセ
ロールなどのアルコール類;フマル酸、クエン酸、酢
酸、プロピオン酸などの有機酸類及びその塩類;パラフ
ィンなどの炭化水素類;これらの混合物などが使用でき
る。窒素源としては、例えば、塩化アンモニウム、硫酸
アンモニウム、リン酸アンモニウムなどの無機酸のアン
モニウム塩;フマル酸アンモニウム、クエン酸アンモニ
ウムなどの有機酸のアンモニウム塩;肉エキス、酵母エ
キス、麦芽エキス、ペプトン、コーンスティープリカ
ー、カゼイン加水分解物、尿素などの無機又は有機含窒
素化合物;これらの混合物を使用できる。また、培地に
は、前記成分以外に、通常の培養に用いられる栄養源、
例えば、無機塩、微量金属塩、ビタミン類などを適宜、
混合して用いることができる。さらに、必要に応じて、
微生物の増殖を促進する因子、培地のpH保持に有効な
物質、本発明の目的化合物の生成能力を高める因子、例
えば、2−オキソ−4−フェニル酪酸なども添加でき
る。
The medium is not particularly limited as long as the microorganism can grow. As the carbon source of the culture medium, any of the above microorganisms can be used, for example, sugars such as glucose, fructose, sucrose, dextrin, starch; alcohols such as sorbitol, ethanol, glycerol; fumaric acid, citric acid Organic acids such as acid, acetic acid and propionic acid and salts thereof; hydrocarbons such as paraffin; mixtures thereof and the like can be used. As the nitrogen source, for example, ammonium salts of inorganic acids such as ammonium chloride, ammonium sulfate and ammonium phosphate; ammonium salts of organic acids such as ammonium fumarate and ammonium citrate; meat extract, yeast extract, malt extract, peptone, corn Inorganic or organic nitrogen-containing compounds such as steep liquor, casein hydrolyzate, and urea; mixtures thereof can be used. In addition, the medium, in addition to the above components, nutrient sources used for normal culture,
For example, inorganic salts, trace metal salts, vitamins and the like as appropriate,
They can be used in combination. In addition, if necessary,
Factors that promote the growth of microorganisms, substances that are effective in maintaining the pH of the medium, and factors that enhance the ability to produce the target compound of the present invention, such as 2-oxo-4-phenylbutyric acid, can also be added.

【0019】微生物の培養は、生育に適した条件下、例
えば、培地のpH3.0〜9.5、好ましくは4〜8、
培養温度20〜45℃、好ましくは25〜37℃の条件
で行なうことができる。微生物の培養は、嫌気的又は好
気的条件下で行なうことができる。培養時間は、例え
ば、5〜120時間、好ましくは12〜72時間程度で
ある。
Cultivation of microorganisms is carried out under conditions suitable for growth, for example, when the pH of the medium is 3.0 to 9.5, preferably 4 to 8,
The cultivation can be carried out at a temperature of 20 to 45 ° C, preferably 25 to 37 ° C. Cultivation of the microorganism can be performed under anaerobic or aerobic conditions. The culturing time is, for example, about 5 to 120 hours, preferably about 12 to 72 hours.

【0020】本発明の酵素は、培養した微生物菌体から
抽出し精製することにより得ることができる。例えば、
培養物を遠心分離に供して菌体を回収し、超音波破砕
や、機械的破砕法と遠心分離法とを組合わせる方法など
により無細胞抽出液を得る。次いで、抽出液を、例え
ば、ストレプトマイシン硫酸処理、硫酸アンモニウム分
画、イオン交換クロマトグラフィー、アフィニティーク
ロマトグラフィー、溶出液による溶出、ゲル濾過法、限
外濾過法などの通常の精製方法を一種又は二種以上組合
せて精製することにより、酵素を得ることができる。
The enzyme of the present invention can be obtained by extracting and purifying from the cultured microbial cells. For example,
The culture is subjected to centrifugation to collect the cells, and a cell-free extract is obtained by sonication or a method combining mechanical crushing and centrifugation. The extract is then treated with one or more ordinary purification methods such as, for example, streptomycin sulfate treatment, ammonium sulfate fractionation, ion exchange chromatography, affinity chromatography, elution with an eluent, gel filtration, and ultrafiltration. By purifying in combination, an enzyme can be obtained.

【0021】以下に、2−オキソ−4−フェニル酪酸か
ら光学活性な(R)−2−ヒドロキシ−4−フェニル酪
酸を製造する方法について説明する。
Hereinafter, a method for producing optically active (R) -2-hydroxy-4-phenylbutyric acid from 2-oxo-4-phenylbutyric acid will be described.

【0022】本発明の方法において、前記理化学的性質
を有する酵素により、基質である2−オキソ−4−フェ
ニル酪酸を不斉還元し、(R)−2−ヒドロキシ−4−
フェニル酪酸を生成させるためには、基質と共に補酵素
NADPHが必要である。
In the method of the present invention, 2-oxo-4-phenylbutyric acid, which is a substrate, is asymmetrically reduced by the enzyme having the above-mentioned physicochemical properties to give (R) -2-hydroxy-4-
In order to produce phenylbutyric acid, coenzyme NADPH is required together with the substrate.

【0023】不斉還元反応は、前記酵素の活性が安定に
発現する条件下、基質、酵素、NADPHを適当な比率
で混合して反応すればよい。反応系のpHは、例えば、
5〜9、好ましくは6〜8程度である。また、反応温度
は、例えば、10〜60℃、好ましくは20〜40℃程
度である。反応は、撹拌下又は静置下、1〜120時間
程度行うことができる。
The asymmetric reduction reaction may be carried out by mixing a substrate, an enzyme and NADPH at an appropriate ratio under conditions where the activity of the enzyme is stably expressed. The pH of the reaction system is, for example,
It is about 5 to 9, preferably about 6 to 8. Further, the reaction temperature is, for example, about 10 to 60 ° C, preferably about 20 to 40 ° C. The reaction can be performed under stirring or standing for about 1 to 120 hours.

【0024】基質の濃度は、目的とする光学活性体の生
成量および光学純度が低下しない限り特に制限されない
が、例えば、0.1〜10重量%程度が好ましい。ま
た、基質と、酵素との比率、補酵素と酵素との比率は、
目的とする光学活性体の生成量および光学純度が低下し
ない範囲で選択できる。
The concentration of the substrate is not particularly limited as long as the production amount and the optical purity of the desired optically active substance are not reduced, but is preferably, for example, about 0.1 to 10% by weight. Also, the ratio of the substrate to the enzyme, the ratio of the coenzyme to the enzyme,
It can be selected within a range where the production amount and optical purity of the desired optically active substance do not decrease.

【0025】また、反応に際して、補酵素を反応系にリ
サイクルするリサイクル系を構築することにより、
(R)−2−ヒドロキシ−4−フェニル酪酸をさらに効
率的に製造できる。補酵素のリサイクル系は、反応液か
ら補助酵素を分離する分離手段、リサイクルラインなど
を組合せる慣用の方法により構築できる。
Also, by constructing a recycling system for recycling the coenzyme to the reaction system during the reaction,
(R) -2-hydroxy-4-phenylbutyric acid can be produced more efficiently. The coenzyme recycling system can be constructed by a conventional method combining a separation means for separating the auxiliary enzyme from the reaction solution, a recycling line, and the like.

【0026】さらに、本発明の酵素は、慣用の方法、例
えば、吸着、包括、共有結合、イオン結合、架橋結合な
どの方法により、種々の固定化担体に固定化することに
より固定化酵素として使用することも可能である。担体
の種類は特に制限されず、例えばポリアクリルアミド、
セルロース系材料、スチレン系ポリマー、DEAE−セ
ファデックス、イオン交換樹脂、コラーゲン、アルブミ
ン、カラギーナン、アルギン酸、寒天などであってもよ
い。
Furthermore, the enzyme of the present invention can be used as an immobilized enzyme by immobilizing it on various immobilized carriers by a conventional method such as adsorption, entrapment, covalent bonding, ionic bonding, cross-linking and the like. It is also possible. The type of the carrier is not particularly limited, for example, polyacrylamide,
Cellulose-based materials, styrene-based polymers, DEAE-Sephadex, ion exchange resins, collagen, albumin, carrageenan, alginic acid, agar, and the like may be used.

【0027】生成した光学活性な(R)−2−ヒドロキ
シ−4−フェニル酪酸は、慣用の分離精製手段により回
収できる。例えば、反応液を、膜分離、有機溶媒による
抽出、カラムクロマトグラフィー、イオン交換樹脂によ
る分離、減圧濃縮、再結晶などの通常の精製方法に供す
ることにより、前記光学活性体を容易に得ることができ
る。なお、光学活性(R)−2−ヒドロキシ−4−フェ
ニル酪酸の光学純度は、例えば、光学異性体分離カラム
を用いた高速液体クロマトグラフィー(HPLC)によ
り測定できる。
The generated optically active (R) -2-hydroxy-4-phenylbutyric acid can be recovered by conventional separation and purification means. For example, the optically active substance can be easily obtained by subjecting the reaction solution to a conventional purification method such as membrane separation, extraction with an organic solvent, column chromatography, separation with an ion exchange resin, concentration under reduced pressure, and recrystallization. it can. The optical purity of the optically active (R) -2-hydroxy-4-phenylbutyric acid can be measured, for example, by high performance liquid chromatography (HPLC) using an optical isomer separation column.

【0028】[0028]

【発明の効果】本発明の新規な酵素は、2−オキソ−4
−フェニル酪酸を選択的に不斉還元し、光学活性な
(R)−2−ヒドロキシ−4−フェニル酪酸を効率よく
生成する。
The novel enzyme of the present invention is 2-oxo-4
-Phenylbutyric acid is selectively asymmetrically reduced to efficiently produce optically active (R) -2-hydroxy-4-phenylbutyric acid.

【0029】本発明の酵素の製造方法によれば、前記の
如き優れた性質を有する酵素を得ることができる。
According to the method for producing an enzyme of the present invention, an enzyme having the above excellent properties can be obtained.

【0030】さらに、本発明の製造方法では、前記酵素
の作用により、2−オキソ−4−フェニル酪酸から光学
活性な(R)−2−ヒドロキシ−4−フェニル酪酸を効
率よく製造できる。
Further, in the production method of the present invention, optically active (R) -2-hydroxy-4-phenylbutyric acid can be efficiently produced from 2-oxo-4-phenylbutyric acid by the action of the enzyme.

【0031】[0031]

【実施例】以下に、実施例に基づいて本発明をより詳細
に説明するが、本発明はこれらの実施例に限定されるも
のではない。
EXAMPLES The present invention will be described below in more detail with reference to examples, but the present invention is not limited to these examples.

【0032】なお、酵素活性は、次のような標準活性測
定法により測定した。
The enzyme activity was measured by the following standard activity measuring method.

【0033】10μMの2−オキソ−4−フェニル酪
酸、0.1μMのNADPH、100μMのリン酸カリ
ウム緩衝液(pH6.0)及び適量の酵素液を含む全容
1mlの反応系を構成し、37℃で、340nmにおけ
るNADPHの吸光度の減少を分光光度計にて追跡し、
酵素活性を求めた。なお、上記条件下で、1分間に、1
μMのNADPHが酸化される酵素量を、酵素活性1単
位(U)とした。
A 1 ml reaction system containing 10 μM 2-oxo-4-phenylbutyric acid, 0.1 μM NADPH, 100 μM potassium phosphate buffer (pH 6.0) and an appropriate amount of an enzyme solution was prepared. Then, the decrease in absorbance of NADPH at 340 nm was tracked with a spectrophotometer,
Enzyme activity was determined. Under the above conditions, 1 minute
The enzyme amount at which μM NADPH was oxidized was defined as 1 unit (U) of the enzyme activity.

【0034】また、比活性は、蛋白質1mg当たりの単
位(U)数として算出した。なお、蛋白量は、牛血清ア
ルブミンを標準物質として用い、ローリイ(Lowry )法
により測定した。
The specific activity was calculated as the number of units (U) per mg of protein. The protein amount was measured by the Lowry method using bovine serum albumin as a standard substance.

【0035】実施例1(酵素の精製) グルコース8%、酵母エキス1%、硫酸マンガン10p
pm、炭酸カルシウム2%より成る組成の培地18Lを
30L容のジャーファーメンターに入れ、加熱殺菌した
後、前記と同様な培地で予め培養したロイコノストック
・デキストラニカムIFO27310の培養液500m
lを植菌した。30℃で、200rpm、気相通気の条
件下、18時間培養した。
Example 1 (Purification of enzyme) Glucose 8%, yeast extract 1%, manganese sulfate 10p
pm, 18 L of a medium having a composition of 2% calcium carbonate was placed in a 30 L jar fermenter, sterilized by heating, and then cultured in a medium similar to that described above in a culture medium of Leuconostoc dextranicum IFO27310, which had been preliminarily cultured in the same medium as described above.
1 was inoculated. The cells were cultured at 30 ° C. under the conditions of 200 rpm and gas phase aeration for 18 hours.

【0036】得られた培養液を遠心分離に供し集菌した
後、生理的食塩水にて洗浄した。得られた湿菌体200
gに10mMリン酸緩衝液(pH7.2)(0.02%
の2−メルカプトエタノールを含む)200mlを加
え、菌体を超音波破砕した。この破砕液を10000
G、10分間遠心分離し、上澄液180mlを得た。
The obtained culture was subjected to centrifugation to collect the bacteria, and then washed with physiological saline. Obtained wet cells 200
g to 10 mM phosphate buffer (pH 7.2) (0.02%
200 ml of 2-mercaptoethanol) was added, and the cells were sonicated. This crushed liquid is 10,000
G, and centrifuged for 10 minutes to obtain 180 ml of a supernatant.

【0037】この粗抽出液を上記と同じ緩衝液で平衡化
したDEAE−セルロースのカラム(10×20cm)
に負荷した。このカラムを前記と同じ緩衝液1Lで洗浄
した後、KCl濃度を順次上げるステップワイズ法で目
的酵素を溶出したところ、0.2M濃度のところで、溶
出した。
A column of DEAE-cellulose (10 × 20 cm) in which the crude extract was equilibrated with the same buffer as above.
Loaded. After the column was washed with 1 L of the same buffer as above, the target enzyme was eluted by the stepwise method of sequentially increasing the KCl concentration.

【0038】この活性画分を限外濾過法で濃縮した後、
前記と同様にして、DEAE−トヨパール650Mのカ
ラム(4×30cm)に負荷し、同様な方法で溶出した
ところ、KCl濃度0.15Mのところで目的酵素が溶
出した。
After the active fraction was concentrated by ultrafiltration,
In the same manner as described above, the column was loaded on a column (4 × 30 cm) of DEAE-Toyopearl 650M and eluted in the same manner. The target enzyme was eluted at a KCl concentration of 0.15M.

【0039】この活性画分を前記と同様に濃縮した後、
0.2MのKClを含む前記と同様の緩衝液で平衡化し
たセルロファインGCL−2000のカラム(2×10
0cm)を用いてゲル濾過を行なった。活性画分を前記
と同様に濃縮し、常法に従ってポリアクリルアミドゲル
電気泳動法により、純度を調べたところ、単一のバンド
として検出され、酵素標品の均一性が確認された。
After concentrating the active fraction in the same manner as described above,
A column of Cellulofine GCL-2000 equilibrated with the same buffer as above containing 0.2 M KCl (2 × 10
(0 cm). The active fraction was concentrated in the same manner as described above, and the purity was examined by polyacrylamide gel electrophoresis according to a conventional method. As a result, it was detected as a single band, and the homogeneity of the enzyme preparation was confirmed.

【0040】精製過程を表1に纏めて示す。The purification process is summarized in Table 1.

【0041】[0041]

【表1】 実施例2(基質特異性) 標準活性測定法に準拠し、実施例1で得られた酵素標品
を用い、表2に記載の各種の基質について反応速度を調
べた。2−オキソ−4−フェニル酪酸に対する活性を1
00とし、得られた結果を、表2に相対活性として示
す。
[Table 1] Example 2 (Substrate Specificity) The reaction rates of various substrates shown in Table 2 were examined using the enzyme preparation obtained in Example 1 in accordance with the standard activity measurement method. The activity against 2-oxo-4-phenylbutyric acid is 1
The results are shown in Table 2 as relative activities.

【0042】なお、この反応において、NADPHをN
ADHで代替できない。
In this reaction, NADPH is converted to N
ADH cannot be substituted.

【0043】[0043]

【表2】 実施例3(至適pH) 実施例1で得られた酵素標品の至適pHを次のようにし
て調べた。すなわち、標準活性測定法に準拠し、緩衝液
の種類及びpHを変化させて、酵素標品の活性を測定し
た。なお、pH調整に際して、pH5〜8の範囲では2
00mMリン酸緩衝液を用い、pH7〜9の範囲では2
00mMトリス−塩酸緩衝液を用いた。
[Table 2] Example 3 (Optimal pH) The optimal pH of the enzyme preparation obtained in Example 1 was examined as follows. That is, the activity of the enzyme preparation was measured by changing the type and pH of the buffer solution according to the standard activity measurement method. When adjusting the pH, the pH was adjusted to 2 in the range of 5 to 8.
Using a 00 mM phosphate buffer, pH 2
A 00 mM Tris-HCl buffer was used.

【0044】リン酸緩衝液(pH6.0)で測定した活
性を100とし、得られた結果を、図1に相対活性とし
て示す。
The activity measured with a phosphate buffer (pH 6.0) is defined as 100, and the obtained results are shown in FIG. 1 as relative activities.

【0045】図1より、リン酸緩衝液において、酵素標
品の至適pHは6付近である。
As shown in FIG. 1, the optimum pH of the enzyme preparation in the phosphate buffer is around 6.

【0046】実施例4(pH安定性) 実施例1で得られた酵素標品のpH安定性を次のように
して調べた。すなわち、pHの異なる緩衝液2mlに酵
素標品0.5mlを添加し、20℃で20分間処理し
た。なお、pH5〜7では200mMリン酸緩衝液、p
H7〜9では200mMトリス−塩酸緩衝液を用いた。
次いで、処理液0.1mlをサンプリングし、1Mリン
酸緩衝液(pH7.0)0.5mlを添加し、酵素を含
む液0.05mlを用い、標準活性測定法により、残存
活性を測定した。
Example 4 (pH stability) The pH stability of the enzyme preparation obtained in Example 1 was examined as follows. That is, 0.5 ml of the enzyme preparation was added to 2 ml of buffers having different pH, and the mixture was treated at 20 ° C. for 20 minutes. At pH 5 to 7, 200 mM phosphate buffer, p
For H7-9, a 200 mM Tris-HCl buffer was used.
Next, 0.1 ml of the treatment solution was sampled, 0.5 ml of a 1 M phosphate buffer (pH 7.0) was added, and the residual activity was measured by a standard activity measurement method using 0.05 ml of a solution containing the enzyme.

【0047】リン酸緩衝液(pH6.0)で処理した場
合の残存活性を100とし、結果を、図2に相対活性と
して示す。
The residual activity when treated with a phosphate buffer (pH 6.0) was defined as 100, and the results are shown in FIG. 2 as relative activities.

【0048】図2より、酵素標品は、リン酸緩衝液にお
いてpH6〜7で安定である。
As shown in FIG. 2, the enzyme preparation is stable at pH 6 to 7 in a phosphate buffer.

【0049】実施例5(至適温度) 実施例1で得られた酵素標品の至適温度を、次のように
して調べた。すなわち、標準活性測定法に準拠して、反
応温度を変化させ、反応速度を測定した。そして、反応
温度45℃での反応速度を100とし、得られた結果を
図3に相対反応速度として示す。
Example 5 (Optimal temperature) The optimal temperature of the enzyme preparation obtained in Example 1 was examined as follows. That is, the reaction temperature was changed and the reaction rate was measured according to the standard activity measurement method. The reaction rate at a reaction temperature of 45 ° C. was set to 100, and the obtained result is shown in FIG. 3 as a relative reaction rate.

【0050】図3より、酵素標品の至適温度は45℃付
近である。
FIG. 3 shows that the optimum temperature of the enzyme preparation is around 45 ° C.

【0051】実施例6(熱安定性) 実施例1で得られた酵素標品の熱安定性を、次のように
して調べた。すなわち、酵素標品に200mMリン酸緩
衝液(pH7.2)を添加し、pHを7.2に調整した
後、異なる温度条件下で20分間処理し、処理液の残存
活性を、標準活性測定法により測定した。そして、20
℃での活性を100とし、結果を図4に残存活性(%)
として示す。
Example 6 (Thermal Stability) The thermal stability of the enzyme preparation obtained in Example 1 was examined as follows. That is, a 200 mM phosphate buffer (pH 7.2) was added to the enzyme preparation to adjust the pH to 7.2, followed by treatment under different temperature conditions for 20 minutes, and the residual activity of the treated solution was measured by standard activity measurement. It was measured by the method. And 20
The activity at 100 ° C. was defined as 100, and the results are shown in FIG.
As shown.

【0052】図4より、酵素標品は40℃以下では安定
である。
FIG. 4 shows that the enzyme preparation is stable at 40 ° C. or lower.

【0053】実施例7(2−オキソ−4−フェニル酪酸
に対するKm値) 実施例1で得られた酵素標品を用い、2−オキソ−4−
フェニル酪酸の濃度を変化させ、標準活性測定法によ
り、活性を測定し、Km値を求めたところ、0.29m
Mであった。
Example 7 (Km value for 2-oxo-4-phenylbutyric acid) Using the enzyme preparation obtained in Example 1, 2-oxo-4-
When the concentration of phenylbutyric acid was changed and the activity was measured by a standard activity measuring method, and the Km value was determined,
M.

【0054】実施例8(阻害剤) 実施例1で得られた酵素標品に対する各種の阻害剤の影
響を、次のようにして調べた。すなわち、標準活性法に
よる反応系に、表7に示す阻害剤を添加し、酵素と共に
30℃で5分間インキュベートした後、NADPHを添
加して反応を開始し、活性を測定した。そして、阻害剤
を添加しない場合の活性を100とし、得られた活性
を、表3に相対活性として示す。
Example 8 (Inhibitor) The influence of various inhibitors on the enzyme preparation obtained in Example 1 was examined as follows. That is, the inhibitors shown in Table 7 were added to the reaction system according to the standard activity method, and the mixture was incubated with the enzyme at 30 ° C. for 5 minutes. Then, NADPH was added to start the reaction, and the activity was measured. The activity when no inhibitor was added was defined as 100, and the obtained activity is shown in Table 3 as a relative activity.

【0055】[0055]

【表3】 表3より、酵素標品の活性は、塩化水銀およびパラクロ
ロ水銀安息香酸で阻害される。
[Table 3] From Table 3, the activity of the enzyme preparation is inhibited by mercuric chloride and parachloromercuric benzoic acid.

【0056】実施例9(分子量) 実施例1で得られた酵素標品の分子量を、HPLC法に
よるゲル濾過法により測定した。すなわち、アサヒパッ
ク(Asahipak)GS−520(0.75×60cm)
(旭化成(株)製)をカラムとして用い、常法により、
HPLC法で分子量を求めたところ、46000であっ
た。
Example 9 (Molecular Weight) The molecular weight of the enzyme preparation obtained in Example 1 was measured by a gel filtration method using an HPLC method. That is, Asahipak GS-520 (0.75 × 60 cm)
(Manufactured by Asahi Kasei Corporation) as a column,
The molecular weight was determined by HPLC to be 46,000.

【0057】実施例10((R)−2−ヒドロキシ−4
−フェニル酪酸の製造) 2−オキソ−4−フェニル酪酸100mgを、20ml
の水に溶解し、1NのNaOHにてpH6とした。この
溶液にNADPH500mgを添加し溶解した後、10
0mMリン酸緩衝液(pH6.0)20mlを添加し
た。次いで、実施例1と同様にして得られた酵素の溶液
5ml(200U)を添加し、30℃で24時間反応し
た。
Example 10 ((R) -2-hydroxy-4)
-Production of phenylbutyric acid) 100 mg of 2-oxo-4-phenylbutyric acid was added to 20 ml
And adjusted to pH 6 with 1N NaOH. After adding and dissolving 500 mg of NADPH to this solution, 10
20 ml of 0 mM phosphate buffer (pH 6.0) was added. Next, 5 ml (200 U) of the enzyme solution obtained in the same manner as in Example 1 was added, and the mixture was reacted at 30 ° C. for 24 hours.

【0058】反応液を、1N硫酸にてpH2.5とし、
塩化ナトリウムを飽和になるまで溶解させ、反応生成物
を酢酸エチル50mlにて2回抽出した。有機層を合わ
せて、溶媒を留去し、粗結晶80mgを得た。この粗結
晶をトルエンで再結晶し、結晶68mg(収率68%)
を得た。
The reaction solution was adjusted to pH 2.5 with 1N sulfuric acid.
Sodium chloride was dissolved until saturated, and the reaction product was extracted twice with 50 ml of ethyl acetate. The organic layers were combined, the solvent was distilled off, and 80 mg of crude crystals were obtained. The crude crystals were recrystallized from toluene to give 68 mg of crystals (68% yield).
I got

【0059】mp:113.5℃ [α]D =−8.5(c=1,エタノール) 得られた結晶を少量の水に溶解し、光学分割カラムを用
いる高速液体クロマトグラフィー(カラム:ダイセル化
学工業(株)製、キラルセルOB、溶媒:n−ヘキサン
/2−プロパノール=19:1)に供し、絶対配置及び
光学純度を測定したところ、生成物と(R)−2−ヒド
ロキシ−4−フェニル酪酸とのリテンションタイムが完
全に一致し、生成物の光学純度も100%e.e.であ
った。
Mp: 113.5 ° C. [α] D = −8.5 (c = 1, ethanol) The obtained crystals are dissolved in a small amount of water, and high-performance liquid chromatography using an optical resolution column (column: Daicel) The product was subjected to a chiral cell OB (solvent: n-hexane / 2-propanol = 19: 1) manufactured by Chemical Industry Co., Ltd., and the absolute configuration and optical purity were measured. The product and (R) -2-hydroxy-4- The retention times with phenylbutyric acid are completely identical and the optical purity of the product is 100% e. e. Met.

【図面の簡単な説明】[Brief description of the drawings]

【図1】実施例3における酵素標品の至適pHを示すた
めのグラフである。
FIG. 1 is a graph showing the optimum pH of an enzyme preparation in Example 3.

【図2】実施例4における酵素標品の安定なpH範囲を
示すためのグラフである。
FIG. 2 is a graph showing a stable pH range of an enzyme preparation in Example 4.

【図3】実施例5における酵素標品の至適温度を示すた
めのグラフである。
FIG. 3 is a graph showing the optimum temperature of an enzyme preparation in Example 5.

【図4】実施例6における酵素標品の安定な温度範囲を
示すためのグラフである。
FIG. 4 is a graph showing a stable temperature range of an enzyme preparation in Example 6.

フロントページの続き (58)調査した分野(Int.Cl.6,DB名) C12N 9/04 C12P 7/52 CA(STN)Continuation of the front page (58) Field surveyed (Int. Cl. 6 , DB name) C12N 9/04 C12P 7/52 CA (STN)

Claims (4)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 下記(1) 〜(8) の理化学的性質を有する
新規酵素。 (1) 作用および基質特異性:還元型ニコチンアミド・ア
デニン・ジヌクレオチド・リン酸の存在下、2−オキソ
−4−フェニル酪酸を不斉還元し、(R)−2−ヒドロ
キシ−4−フェニル酪酸を生成する (2) 至適pH:6.0付近(リン酸緩衝液) (3) 安定pH範囲:6〜7(リン酸緩衝液) (4) 至適温度:45℃付近(pH6.0) (5) 熱安定性:40℃以下で安定(pH7.2、処理時
間20分) (6) 2−オキソ−4−フェニル酪酸に対するミハエリス
定数Km値:0.29mM (7) 分子量:46000(ゲル濾過法) (8) 阻害剤:塩化水銀およびパラクロロ水銀安息香酸
1. A novel enzyme having the following physicochemical properties (1) to (8). (1) Action and substrate specificity: Asymmetric reduction of 2-oxo-4-phenylbutyric acid in the presence of reduced nicotinamide / adenine / dinucleotide / phosphoric acid to give (R) -2-hydroxy-4-phenyl (2) Optimum pH: around 6.0 (phosphate buffer) (3) Stable pH range: 6-7 (phosphate buffer) (4) Optimum temperature: around 45 ° C. (pH 6.0) 0) (5) Thermal stability: stable at 40 ° C. or less (pH 7.2, treatment time: 20 minutes) (6) Michaelis constant Km value for 2-oxo-4-phenylbutyric acid: 0.29 mM (7) Molecular weight: 46,000 (Gel filtration method) (8) Inhibitors: mercuric chloride and parachloromercuric benzoic acid
【請求項2】 還元型ニコチンアミド・アデニン・ジヌ
クレオチド・リン酸の存在下、アルデヒド類及びケトン
類を還元し、これらに対応する等モルのアルコールを生
成する請求項1記載の新規酵素。
2. The novel enzyme according to claim 1, wherein aldehydes and ketones are reduced in the presence of reduced nicotinamide / adenine / dinucleotide / phosphate to produce an equimolar alcohol corresponding thereto.
【請求項3】 ロイコノストック(Leuconostoc)属に属
する微生物を培養し、該培養物から、請求項1記載の酵
素を採取する、新規酵素の製造方法。
3. A method for producing a novel enzyme, comprising culturing a microorganism belonging to the genus Leuconostoc and collecting the enzyme according to claim 1 from the culture.
【請求項4】 還元型ニコチンアミド・アデニン・ジヌ
クレオチド・リン酸の存在下、請求項1記載の酵素を、
2−オキソ−4−フェニル酪酸に作用させて不斉還元す
る、光学活性な(R)−2−ヒドロキシ−4−フェニル
酪酸の製造方法。
4. The enzyme according to claim 1, which is in the presence of reduced nicotinamide / adenine / dinucleotide / phosphate.
A method for producing optically active (R) -2-hydroxy-4-phenylbutyric acid, which is asymmetrically reduced by acting on 2-oxo-4-phenylbutyric acid.
JP3131964A 1991-05-07 1991-05-07 Novel enzyme, method for producing the same, and method for producing optically active (R) -2-hydroxy-4-phenylbutyric acid Expired - Fee Related JP2750017B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3131964A JP2750017B2 (en) 1991-05-07 1991-05-07 Novel enzyme, method for producing the same, and method for producing optically active (R) -2-hydroxy-4-phenylbutyric acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3131964A JP2750017B2 (en) 1991-05-07 1991-05-07 Novel enzyme, method for producing the same, and method for producing optically active (R) -2-hydroxy-4-phenylbutyric acid

Publications (2)

Publication Number Publication Date
JPH04335886A JPH04335886A (en) 1992-11-24
JP2750017B2 true JP2750017B2 (en) 1998-05-13

Family

ID=15070341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3131964A Expired - Fee Related JP2750017B2 (en) 1991-05-07 1991-05-07 Novel enzyme, method for producing the same, and method for producing optically active (R) -2-hydroxy-4-phenylbutyric acid

Country Status (1)

Country Link
JP (1) JP2750017B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006059237A1 (en) * 2004-08-30 2006-06-08 Lunamed, Inc. 4-phenylbutyric acid controlled-release formulations for therapeutic use

Also Published As

Publication number Publication date
JPH04335886A (en) 1992-11-24

Similar Documents

Publication Publication Date Title
EP0606899A2 (en) Processes for production of optically active 4-halo-3-hydroxybutyric acid esters
JPH06233695A (en) Stereoselective reduction of ketones
EP0496001A1 (en) Process for producing optically active 3-phenyl-1,3-propanediol
US5888804A (en) Processes for production of optically active quinuclidinol
JP3858505B2 (en) Method for producing R-3-quinuclidinol
CA2200420A1 (en) Process for producing aspartase and process for producing l-aspartic acid
EP0142169B1 (en) 2,5-diketo-d-gluconic acid reductase
JPS6012975A (en) Microbiologically obtained d-2-hydroxy-4-methyl pentanoic acid-dhydrogenase and method for obtaining same
WO2007026860A1 (en) METHOD FOR PRODUCTION OF OPTICALLY ACTIVE α-HYDROXYCARBOXYLIC ACID
JP2750017B2 (en) Novel enzyme, method for producing the same, and method for producing optically active (R) -2-hydroxy-4-phenylbutyric acid
US4689296A (en) Method of preparing novel thermostable transglucosidase
JP3492776B2 (en) Method for producing cis-3-hydroxy-L-proline
JP2801694B2 (en) New enzyme
US5322782A (en) Method of synthesizing optically active β-halolactic acid
JP2005117905A (en) Method for producing optically active 1-benzyl-3-pyrrolidinol
JP3055711B2 (en) Method for producing optically active (S) -3-phenyl-1,3-propanediol
JP3917723B2 (en) Lactone hydrolase and process for producing the same
JP2624296B2 (en) Method for producing γ-halo-β-hydroxybutyrate
JP2005517442A (en) Enone reductase
JP2538597B2 (en) Novel ring enzyme
JPH04341195A (en) Production of optically active mandelic acid
JP3843692B2 (en) Process for the production of optically active endo-norborneol
US20010036660A1 (en) Method of producing optically active N-methylamino acids
JPH1075797A (en) Production of (r)-2-hydroxy-4-phenyl-3-butenoic acid by enzymatic method
JP2946055B2 (en) Method for producing optically active (S)-(+)-3-halo-1,2-propanediol

Legal Events

Date Code Title Description
S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313532

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080220

Year of fee payment: 10

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080220

Year of fee payment: 10

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080220

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090220

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100220

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100220

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110220

Year of fee payment: 13

LAPS Cancellation because of no payment of annual fees